Abstract
The pancreas is a relatively small organ, but it has structural and functional complexity that makes it difficult to understand underlying disease mechanisms and determine effective treatments. Thus, there is a great need for more effective tools to study pancreatic disease, and breakthroughs in various fields have contributed to development of in vitro tissue models to understand the pathophysiological conditions of pancreatic disease. Here, we provide an overview of three major parts of the strategies in pancreatic tissue modeling. The advent of stem cell technology enables large-scale production of cells, which can represent individual patients’ information. The biomaterials provide cells with a three-dimensional (3D) geometry to mimic the nature of cell—matrix contacts. With the benefits of 3D culture systems, decellularized extracellular matrix materials have been introduced as a promising tool for providing tissue-specific niches to cells. In addition, several biofabrication strategies allow modeling of structural complexities including cell deposition and neighboring environment, as compared to standard embedding cells in matrix. Integration of these strategies can overcome the current challenges to each approach and guide the path towards the next generation of 3D pancreatic tissue modeling for translational medicine.
Similar content being viewed by others
References
Ellis, C., Ramzy, A. & Kieffer, T.J. Regenerative medicine and cell-based approaches to restore pancreatic function. Nat. Rev. Gastroenterol. Hepatol.14, 612–628 (2017).
Caicedo, A. Paracrine and autocrine interactions in the human islet: more than meets the eye. Semin. Cell Dev. Biol.24 11–21 (2013).
Bakhti, M., Böttcher, A. & Lickert, H. Modelling the endocrine pancreas in health and disease. Nat. Rev. Endocrinol.15, 155–171 (2019).
Rask-Madsen, C. & Kahn, C.R. Tissue—specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler., Thromb., Vasc. Biol.32, 2052–2059 (2012).
Latres, E., Finan, D.A., Greenstein, J.L., Kowalski, A. & Kieffer, T.J. Navigating two roads to glucose normalization in diabetes: automated insulin delivery devices and cell therapy. Cell Metab.29, 545–563 (2019).
Roden, M. & Shulman, G.I. The integrative biology of type 2 diabetes. Nature576, 51–60 (2019).
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C.D., Biankin, A.V., Neale, R.E., Tempero, M., Tuveson, D.A. & Hruban, R.H. Pancreatic cancer. Nat. Rev. Dis. Primers2, 16022 (2016).
Laurent, J., Blin, G., Chatelain, F., Vanneaux, V., Fuchs, A., Larghero, J. & Thery, M. Convergence of microengineering and cellular self-organization towards functional tissue manufacturing. Nat. Biomed. Eng.1, 939–956 (2017).
Rossi, G., Manfrin, A. & Lutolf, M.P. Progress and potential in organoid research. Nat. Rev. Genet.19, 671–687 (2018).
Pagliuca, F.W., Jeffrey R.M., Gürtler, M., Segel, M., Van Dervort, A., Ryu, J.H., Peterson, Q.P., Greiner, D. & Melton, D.A. Generation of Functional Human Pancreatic β Cells In Vitro. Cell159, 428–439 (2014).
Rezania, A., Bruin, J.E., Arora, P., Rubin, A., Batushansky, I., Asadi, A., O’Dwyer, S., Quiskamp, N., Mojibian, M., Albrecht, T., Yang, Y.H.C., Johnson, J.D. & Kieffer, T.J. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol.32, 1121–1133 (2014).
Kieffer, T.J., Woltjen, K., Osafune, K., Yabe, D. & Inagaki, N. Beta-cell replacement strategies for diabetes. J. Diabetes Invest.9, 457–463 (2018).
Millman, J.R., Xie, C., Van Dervort, A., Gürtler, M., Pagliuca, F.W. & Melton, D.A. Generation of stem cell-derived β-cells from patients with type 1 diabetes. Nat. Commun.7, 11463 (2016).
Bruin, J.E., Rezania, A. & Kieffer, T.J. Replacing and safeguarding pancreatic β cells for diabetes. Sci. Transl. Med.7, 316ps323–316ps323 (2015).
Takahashi, Y., Sekine, K., Kin, T., Takebe, T. & Taniguchi, H. Self-condensation culture enables vascularization of tissue fragments for efficient therapeutic transplantation. Cell Rep.23, 1620–1629 (2018).
Driehuis, E., van Hoeck, A., Moore, K., Kolders, S., Francies, H.E., Gulersonmez, M.C., Stigter, E.C.A., Burgering, B., Geurts, V., Gracanin, A., Bounova, G., Morsink, F.H., Vries, R., Boj, S., van Es, J., Offerhaus, G.J.A., Kranenburg, O., Garnett, M.J., Wessels, L., Cuppen, E., Brosens, L.A.A. & Clevers, H. Pancreatic cancer organoids recapitulate disease and allow personalized drug screening. Proc. Natl. Acad. Sci.116, 26580 (2019).
Balak, J.R., Juksar, J., Carlotti, F., Nigro, A.L. & de Koning, E.J. Organoids from the Human Fetal and Adult Pancreas. Curr. Diabetes Rep.19, 160 (2019).
Tao, T., Wang, Y., Chen, W., Li, Z., Su, W., Guo, Y., Deng, P. & Qin, J. Engineering human islet organoids from iPSCs using an organ-on-chip platform. Lab Chip19, 948–958 (2019).
Drost, J. & Clevers, H. Organoids in cancer research. Nat. Rev. Cancer18, 407–418 (2018).
Kratochvil, M.J., Seymour, A.J., Li, T.L., Paşca, S.P., Kuo, C.J. & Heilshorn, S.C. Engineered materials for organoid systems. Nat. Rev. Mater.4, 606–622 (2019).
Daoud, J.T., Petropavlovskaia, M.S., Patapas, J.M., Degrandpré, C.E., DiRaddo, R.W., Rosenberg, L. & Tabrizian, M. Long-term in vitro human pancreatic islet culture using three-dimensional microfabricated scaffolds. Biomaterials32, 1536–1542 (2011).
Han, W., Singh, N.K., Kim, J.J., Kim, H., Kim, B.S., Park, J.Y., Jang, J. & Cho, D.-W. Directed differential behaviors of multipotent adult stem cells from decellularized tissue/organ extracellular matrix bio-inks. Biomaterials224, 119496 (2019).
Kim, J., Shim, I.K., Hwang, D.G., Lee, Y.N., Kim, M., Kim, H., Kim, S.-W., Lee, S., Kim, S.C. & Cho, D.-W. 3D cell printing of islet-laden pancreatic tissue-derived extracellular matrix bioink constructs for enhancing pancreatic functions. J. Mater. Chem. B7, 1773–1781 (2019).
Kim, J., Kim, M., Hwang, D.G., Shim, I.K., Kim, S. C. & Jang, J. Pancreatic Tissue-Derived Extracellular Matrix Bioink for Printing 3D Cell-Laden Pancreatic Tissue Constructs. J. Visualized Exp.154, e60434 (2019).
Takebe, T., Zhang, B. & Radisic, M. Synergistic engineering: organoids meet organs-on-a-chip. Cell Stem Cell21, 297–300 (2017).
Jun, Y., Lee, J., Choi, S., Yang, J.H., Sander, M., Chung, S. & Lee, S.-H. In vivo—mimicking micro-fluidic perfusion culture of pancreatic islet spheroids. Sci. Adv.5, eaax4520 (2019).
Sipos, B., Kojima, M., Tiemann, K., Klapper, W., Kruse, M.-L., Kalthoff, H., Schniewind, B., Tepel, J., Weich, H., Kerjaschki, D. & Klöppel, G. Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis. J. Pathol.207, 301–312 (2005).
Lenggenhager, D., Amrutkar, M., Sántha, P., Aasrum, M., Löhr, J.-M., Gladhaug, P.I. & Verbeke, S.C. Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells. Cells DOI https://doi.org/10.3390/cells8010023 (2019).
Adams, G.G., Uddin, A., Vives-Pi, M. & Pujol-Borrell, R. Characterisation of the NES2Y cell line and its use in the production of human glucose- responsive insulin producing (hGRIP) cell lines by cell-cell fusion. Islets1, 117–123 (2009).
McCluskey, J.T., Hamid, M., Guo-Parke, H., McClenaghan, N.H., Gomis, R. & Flatt, P.R. Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion. J. Biol. Chem.286, 21982–21992 (2011).
Narushima, M., Kobayashi, N., Okitsu, T., Tanaka, Y., Li, S.-A., Chen, Y., Miki, A., Tanaka, K., Nakaji, S., Takei, K., Gutierrez, A.S., Rivas-Carrillo, J.D., Navarro-Álvarez, N., Jun, H.-S., Westerman, K.A., Noguchi, H., Lakey, J.R.T., Leboulch, P., Tanaka, N. & Yoon, J.-W. A human β-cell line for transplantation therapy to control type 1 diabetes. Nat. Biotechnol.23, 1274–1282 (2005).
Ravassard, P., Hazhouz, Y., Pechberty, S., Bricout-Neveu, E., Armanet, M., Czernichow, P. & Scharfmann, R. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion. J. Clin. Invest.121, 3589–3597 (2011).
Baroni, M.G., Cavallo, M.G., Mark, M., Monetini, L., Stoehrer, B. & Pozzilli, P. Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM. J. Endocrinol.161, 59–68 (1999).
Soldevila, G., Buscema, M., Marini, V., Sutton, R., James, R.F.L., Bloom, S.R., Robertson, R.P., Mirakian, R., Pujol-Borrell, R. & Bottazzo, G.F. Transfection with SV40 gene of human pancreatic endocrine cells. J. Autoimmun.4, 381–396 (1991).
Serebriiskii, I., Castelló-Cros, R., Lamb, A., Golemis, E.A. & Cukierman, E. Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cells. Matrix Biol.27, 573–585 (2008).
Lightfoot, Y.L., Chen, J. & Mathews, C.E. Immunemediated β-cell death in type 1 diabetes: lessons from human β-cell lines. Eur. J. Clin. Invest.42, 1244–1251 (2012).
Baker, L.A., Tiriac, H., Clevers, H. & Tuveson, D.A. Modeling Pancreatic Cancer with Organoids. Trends Cancer2, 176–190 (2016).
Gunton, J.E., Kulkarni, R.N., Yim, S., Okada, T., Hawthorne, W.J., Tseng, Y.-H., Roberson, R.S., Ricordi, C., O’Connell, P.J., Gonzalez, F.J. & Kahn, C.R. Loss of ARNT/HIF1β Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes. Cell122, 337–349 (2005).
Benam, K.H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H.J., MacQueen, L., Mahmoodian, R., Musah, S., Torisawa, Y.-S., Meer, A.D.v.d., Villenave, R., Yadid, M., Parker, K.K. & Ingber, D.E. Engineered In Vitro Disease Models. Annu. Rev. Pathol.10, 195–262 (2015).
McCall, Michael D., Toso, C., Baetge, Emmanuel E. & Shapiro, A.M.J. Are stem cells a cure for diabetes? Clin. Sci.118, 87–97 (2009).
Domínguez-Bendala, J., Inverardi, L. & Ricordi, C. Stem cell-derived islet cells for transplantation. Curr. Opin. Organ Transplant.16, 76–82 (2011).
Shahjalal, H.M., Abdal Dayem, A., Lim, K.M., Jeon, T.-i. & Cho, S.-G. Generation of pancreatic β cells for treatment of diabetes: advances and challenges. Stem Cell Res. Ther.9, 355 (2018).
Sayed, N., Liu, C. & Wu, J.C. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. J. Am. Coll. Cardiol.67, 2161–2176 (2016).
Wan, J., Huang, Y., Zhou, P., Guo, Y., Wu, C., Zhu, S., Wang, Y., Wang, L., Lu, Y. & Wang, Z. Culture of iPSCs derived pancreatic β-like cells in vitro using decellularized pancreatic scaffolds: a preliminary trial. Biomed Res. Int.2017, 4276928 (2017).
Shahjalal, H.M., Shiraki, N., Sakano, D., Kikawa, K., Ogaki, S., Baba, H., Kume, K. & Kume, S. Generation of insulin- producing β-like cells from human iPS cells in a defined and completely xeno-free culture system. J. Mol. Cell Biol. (Oxford, U. K.)6, 394–408 (2014).
Yabe, S.G., Fukuda, S., Takeda, F., Nashiro, K., Shimoda, M. & Okochi, H. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells. J. Diabetes9, 168–179 (2017).
Yabe, S.G., Fukuda, S., Nishida, J., Takeda, F., Nashiro, K. & Okochi, H. Induction of functional islet-like cells from human iPS cells by suspension culture. Regenerative Therapy10, 69–76 (2019).
Hosokawa, Y., Toyoda, T., Fukui, K., Baden, M.Y., Funato, M., Kondo, Y., Sudo, T., Iwahashi, H., Kishida, M., Okada, C., Watanabe, A., Asaka, I., Osafune, K., Imagawa, A. & Shimomura, I. Insulin-producing cells derived from ‘induced pluripotent stem cells’ of patients with fulminant type 1 diabetes: Vulnerability to cytokine insults and increased expression of apoptosis-related genes. J. Diabetes Invest.9, 481–493 (2018).
Boj, S.F., Hwang, C.-I., Baker, L.A., Chio, I.I.C., Engle, D.D., Corbo, V., Jager, M., Ponz-Sarvise, M., Tiriac, H., Spector, M.S., Gracanin, A., Oni, T., Yu, K.H., van Boxtel, R., Huch, M., Rivera, K.D., Wilson, J.P., Feigin, M.E., Öhlund, D., Handly-Santana, A., Ardito-Abraham, C.M., Ludwig, M., Elyada, E., Alagesan, B., Biffi, G., Yordanov, G.N., Delcuze, B., Creighton, B., Wright, K., Park, Y., Morsink, F.H. M., Molenaar, I.Q., Rinkes, I.H.B., Cuppen, E., Hao, Y., Jin, Y., Nijman, I.J., Iacobuzio-Donahue, C., Leach, S.D., Pappin, D.J., Hammell, M., Klimstra, D.S., Basturk, O., Hruban, R.H., Offerhaus, G.J., Vries, R.G.J., Clevers, H. & Tuveson, D.A. Organoid Models of Human and Mouse Ductal Pancreatic Cancer. Cell160, 324–338 (2015).
Balboa, D., Saarimäki-Vire, J. & Otonkoski, T. Concise Review: Human Pluripotent Stem Cells for the Modeling of Pancreatic β-Cell Pathology. Stem Cells37, 33–41 (2019).
Clevers, H. & Tuveson, D.A. Organoid Models for Cancer Research. Annu. Rev. Cancer Biol.3, 223–234 (2019).
Kim, J., Hoffman, J.P., Alpaugh, R.K., Rhim, A.D., Reichert, M., Stanger, B.Z., Furth, E.E., Sepulveda, A.R., Yuan, C.-X., Won, K.-J., Donahue, G., Sands, J., Gumbs, A.A. & Zaret, K.S. An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression. Cell Rep.3, 2088–2099 (2013).
Huang, L., Holtzinger, A., Jagan, I., BeGora, M., Lohse, I., Ngai, N., Nostro, C., Wang, R., Muthuswamy, L.B., Crawford, H.C., Arrowsmith, C., Kalloger, S.E., Renouf, D.J., Connor, A.A., Cleary, S., Schaeffer, D.F., Roehrl, M., Tsao, M.-S., Gallinger, S., Keller, G. & Muthuswamy, S.K. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell— and patient-derived tumor organoids. Nat. Med.21, 1364–1371 (2015).
Takebe, T., Enomura, M., Yoshizawa, E., Kimura, M., Koike, H., Ueno, Y., Matsuzaki, T., Yamazaki, T., Toyohara, T., Osafune, K., Nakauchi, H., Yoshikawa, Hiroshi Y. & Taniguchi, H. Vascularized and Complex Organ Buds from Diverse Tissues via Mesenchymal Cell- Driven Condensation. Cell Stem Cell16, 556–565 (2015).
Lebreton, F., Lavallard, V., Bellofatto, K., Bonnet, R., Wassmer, C.H., Perez, L., Kalandadze, V., Follenzi, A., Boulvain, M., Kerr-Conte, J., Goodman, D.J., Bosco, D., Berney, T. & Berishvili, E. Insulin-producing organoids engineered from islet and amniotic epithelial cells to treat diabetes. Nat. Commun.10, 4491 (2019).
von Ahrens, D., Bhagat, T.D., Nagrath, D., Maitra, A. & Verma, A. The role of stromal cancer-associated fibroblasts in pancreatic cancer. J. Hematol. Oncol.10, 76 (2017).
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L. & Yin, R. Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J. Hematol. Oncol.12, 86 (2019).
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A.S., Ponz-Sarvise, M., Corbo, V., Oni, T.E., Hearn, S.A., Lee, E.J., Chio, I.I.C., Hwang, C.-I., Tiriac, H., Baker, L.A., Engle, D.D., Feig, C., Kultti, A., Egeblad, M., Fearon, D.T., Crawford, J.M., Clevers, H., Park, Y. & Tuveson, D.A. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J. Exp. Med.214, 579–596 (2017).
Chan, B.P. & Leong, K.W. Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur. Spine J.17, 467–479 (2008).
Jang, J. 3D Bioprinting and In Vitro Cardiovascular Tissue Modeling. Bioengineering (Basel)4, 71 (2017).
Bochenek, M.A., Veiseh, O., Vegas, A.J., McGarrigle, J.J., Qi, M., Marchese, E., Omami, M., Doloff, J.C., Mendoza-Elias, J., Nourmohammadzadeh, M., Khan, A., Yeh, C.-C., Xing, Y., Isa, D., Ghani, S., Li, J., Landry, C., Bader, A.R., Olejnik, K., Chen, M., Hollister-Lock, J., Wang, Y., Greiner, D.L., Weir, G.C., Strand, B.L., Rokstad, A.M.A., Lacik, I., Langer, R., Anderson, D.G. & Oberholzer, J. Alginate encapsulation as long-term immune protection of allogeneic pancreatic islet cells transplanted into the omental bursa of macaques. Nat. Biomed. Eng.2, 810–821 (2018).
Kumar, N., Joisher, H. & Ganguly, A. Polymeric Scaffolds for Pancreatic Tissue Engineering: A Review. Rev. Diabet. Stud.14, 334–353 (2018).
Ma, F., Tremmel, D.M., Li, Z., Lietz, C.B., Sackett, S.D., Odorico, J.S. & Li, L. In depth quantification of extracellular matrix proteins from human pancreas. J. Proteome Res.18, 3156–3165 (2019).
Sackett, S.D., Tremmel, D.M., Ma, F., Feeney, A.K., Maguire, R.M., Brown, M.E., Zhou, Y., Li, X., O’Brien, C., Li, L., Burlingham, W.J. & Odorico, J.S. Extracellular matrix scaffold and hydrogel derived from decellularized and delipidized human pancreas. Sci. Rep.8, 10452 (2018).
Llacua, L.A., Faas, M.M. & de Vos, P. Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets. Diabetologia61, 1261–1272 (2018).
Otonkoski, T., Banerjee, M., Korsgren, O., Thornell, L.E. & Virtanen, I. Unique basement membrane structure of human pancreatic islets: implications for β-cell growth and differentiation. Diabetes, Obes. Metab.10, 119–127 (2008).
Jiang, F.-X. & Harrison, L.C. Laminin-1 and epidermal growth factor family members co-stimulate fetal pancreas cell proliferation and colony formation. Differentiation73, 45–49 (2005).
Daoud, J., Petropavlovskaia, M., Rosenberg, L. & Tabrizian, M. The effect of extracellular matrix components on the preservation of human islet function in vitro. Biomaterials31, 1676–1682 (2010).
Lin, H.-Y., Tsai, C.-C., Chen, L.-L., Chiou, S.-H., Wang, Y.-J. & Hung, S.-C. Fibronectin and laminin promote differentiation of human mesenchymal stem cells into insulin producing cells through activating Akt and ERK. J. Biomed. Sci.17, 56 (2010).
Jalili, R.B., Moeen Rezakhanlou, A., Hosseini-Tabatabaei, A., Ao, Z., Warnock, G.L. & Ghahary, A. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal. J. Cell. Physiol.226, 1813–1819 (2011).
Llacua, L.A., Hoek, A., de Haan, B.J. & de Vos, P. Collagen type VI interaction improves human islet survival in immunoisolating microcapsules for treatment of diabetes. Islets10, 60–68 (2018).
Rubiano, A., Delitto, D., Han, S., Gerber, M., Galitz, C., Trevino, J., Thomas, R.M., Hughes, S.J. & Simmons, C.S. Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties. Acta Biomater.67, 331–340 (2018).
Cramer, G.M., Jones, D.P., El-Hamidi, H. & Celli, J.P. ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma. Mol. Cancer Res.15, 15 (2017).
Jee, J.H., Lee, D.H., Ko, J., Hahn, S., Jeong, S.Y., Kim, H.K., Park, E., Choi, S.Y., Jeong, S., Lee, J.W., Cho, H.-J., Kwon, M.-S. & Yoo, J. Development of Collagen-Based 3D Matrix for Gastrointestinal Tract-Derived Organoid Culture. Stem Cells Int.2019, 8472712 (2019).
Pati, F., Jang, J., Ha, D.-H., Won Kim, S., Rhie, J.-W., Shim, J.-H., Kim, D.-H. & Cho, D.-W. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat. Commun.5, 3935 (2014).
Jang, J., Kim, T.G., Kim, B.S., Kim, S.-W., Kwon, S.-M. & Cho, D.-W. Tailoring mechanical properties of decellularized extracellular matrix bioink by vitamin B2-induced photo-crosslinking. Acta Biomater.33, 88–95 (2016).
Jang, J., Park, H.-J., Kim, S.-W., Kim, H., Park, J.Y., Na, S.J., Kim, H.J., Park, M.N., Choi, S.H., Park, S.H., Kim, S.W., Kwon, S.-M., Kim, P.-J. & Cho, D.-W. 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair. Biomaterials112, 264–274 (2017).
Jiang, K., Chaimov, D., Patel, S.N., Liang, J.P., Wiggins, S.C., Samojlik, M.M., Rubiano, A., Simmons, C.S. & Stabler, C.L. 3-D physiomimetic extracellular matrix hydrogels provide a supportive microenvironment for rodent and human islet culture. Biomaterials198, 37–48 (2019).
Giobbe, G.G., Crowley, C., Luni, C., Campinoti, S., Khedr, M., Kretzschmar, K., De Santis, M.M., Zambaiti, E., Michielin, F., Meran, L., Hu, Q., van Son, G., Urbani, L., Manfredi, A., Giomo, M., Eaton, S., Cacchiarelli, D., Li, V.S.W., Clevers, H., Bonfanti, P., Elvassore, N. & De Coppi, P. Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture. Nat. Commun.10, 5658 (2019).
Sung, J.H., Koo, J. & Shuler, M.L. Mimicking the Human Physiology with Microphysiological Systems (MPS). BioChip J., 1–12 (2019).
Zhang, B., Korolj, A., Lai, B.F.L. & Radisic, M. Advances in organ-on-a-chip engineering. Nat. Rev. Mater.3, 257–278 (2018).
Bauer, S., Huldt, C.W., Kanebratt, K.P., Durieux, I., Gunne, D., Andersson, S., Ewart, L., Haynes, W.G., Maschmeyer, I. & Winter, A. Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model. Sci. Rep.7, 14620 (2017).
Choi, Y.-J., Jun, Y.-J., Kim, D.Y., Yi, H.-G., Chae, S.-H., Kang, J., Lee, J., Gao, G., Kong, J.-S. & Jang, J. A 3D cell printed muscle construct with tissue-derived bioink for the treatment of volumetric muscle loss. Biomaterials206, 160–169 (2019).
Liu, X., Carter, S.-S.D., Renes, M.J., Kim, J., Rojas-Canales, D.M., Penko, D., Angus, C., Beirne, S., Drogemuller, C.J., Yue, Z., Coates, P.T. & Wallace, G.G. Development of a Coaxial 3D Printing Platform for Biofabrication of Implantable Islet- Containing Constructs. Adv. Healthcare Mater.8, 1801181 (2019).
Gao, G., Kim, B.S., Jang, J. & Cho, D.-W. Recent strategies in extrusion-based three-dimensional cell printing toward organ biofabrication. ACS Biomater. Sci. Eng.5, 1150–1169 (2019).
Jang, J., Yi, H.-G. & Cho, D.-W. 3D printed tissue models: present and future. ACS Biomater. Sci. Eng.2, 1722–1731 (2016).
Glieberman, A.L., Pope, B.D., Zimmerman, J.F., Liu, Q., Ferrier, J.P., Kenty, J.H., Schrell, A.M., Mukhitov, N., Shores, K.L. & Tepole, A.B. Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing. Lab Chip19, 2993–3010 (2019).
Polacheck, W.J., Li, R., Uzel, S.G. & Kamm, R.D. Microfluidic platforms for mechanobiology. Lab Chip13, 2252–2267 (2013).
Lee, S.H., Hong, S., Song, J., Cho, B., Han, E.J., Kondapavulur, S., Kim, D. & Lee, L.P. Microphysiological analysis platform of pancreatic islet β-cell spheroids. Adv. Healthcare Mater.7, 1701111 (2018).
Yi, H.-G., Jeong, Y.H., Kim, Y., Choi, Y.-J., Moon, H.E., Park, S.H., Kang, K.S., Bae, M., Jang, J. & Youn, H. A bioprinted human-glioblastoma- on-a-chip for the identification of patient-specific responses to chemoradiotherapy. Nat. Biomed. Eng.3, 509–519 (2019).
Lee, J.B., Park, J.S., Shin, Y.M., Lee, D.H., Yoon, J.K., Kim, D.H., Ko, U.H., Kim, Y., Bae, S.H. & Sung, H.J. Implantable Vascularized Liver Chip for Cross-Validation of Disease Treatment with Animal Model. Adv. Funct. Mater.29, 1900075 (2019).
Nguyen, D.-H.T., Lee, E., Alimperti, S., Norgard, R.J., Wong, A., Lee, J.J.-K., Eyckmans, J., Stanger, B.Z. & Chen, C.S. A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling. Sci. Adv.5, eaav6789 (2019).
Gioeli, D., Snow, C.J., Simmers, M.B., Hoang, S.A., Figler, R.A., Allende, J.A., Roller, D.G., Parsons, J.T., Wulfkuhle, J.D. & Petricoin, E.F. Development of a multicellular pancreatic tumor microenvironment system using patient-derived tumor cells. Lab Chip19, 1193–1204 (2019).
Marchioli, G., van Gurp, L., Van Krieken, P., Stamatialis, D., Engelse, M., Van Blitterswijk, C., Karperien, M., de Koning, E., Alblas, J. & Moroni, L. Fabrication of three-dimensional bioplotted hydrogel scaffolds for islets of Langerhans transplantation. Biofabrication7, 025009 (2015).
Gao, G., Lee, J.H., Jang, J., Lee, D.H., Kong, J.S., Kim, B.S., Choi, Y.J., Jang, W.B., Hong, Y.J. & Kwon, S.M. Tissue engineered bio-blood-vessels constructed using a tissue-specific bioink and 3D coaxial cell printing technique: a novel therapy for ischemic disease. Adv. Funct. Mater.27, 1700798 (2017).
Das, S., Kim, S.-W., Choi, Y.-J., Lee, S., Lee, S.-H., Kong, J.-S., Park, H.-J., Cho, D.-W. & Jang, J. Decellularized extracellular matrix bioinks and the external stimuli to enhance cardiac tissue development in vitro. Acta Biomater. (2019).
Acknowledgements
This journal was supported by the Bio & Medical Technology Development program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2017M3A9C6032 067) and “ICT Consilience Creative Program” (IITP-2019-2011-1-00783) supervised by the IITP (Institute for Information & communications Technology Planning & Evaluation).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interests The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kim, M., Hwang, D.G. & Jang, J. 3D Pancreatic Tissue Modeling in vitro: Advances and Prospects. BioChip J 14, 84–99 (2020). https://doi.org/10.1007/s13206-020-4108-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-020-4108-4